Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE) & More Heading Into 2016
Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks.
Dyax Corp (DYAX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hood River Capital Management David Swank | 0 | $0 | 0% | |
| 2. | Davidson Kempner Thomas Lenox Kempner | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | Paloma Partners Donald Sussman | 0 | $0 | 0% | |
| 5. | Ancora Advisors Frederick Disanto | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.50 | 5,000 | $12,500.00 | 22,971 | 2013-05-16 | Filing | |
| $2.47 | 5,000 | $12,350.00 | 17,971 | 2013-05-16 | Filing | |
| $2.47 | 5,000 | $12,350.00 | 12,971 | 2013-05-14 | Filing | |
| $2.45 | 2,971 | $7,278.95 | 7,971 | 2013-05-14 | Filing | |
| $2.44 | 800 | $1,952.00 | 5,000 | 2013-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.25 | 1,000 | $22,253.00 | 997,336 | 2015-09-10 | Filing | |
| $22.25 | 1,000 | $22,253.00 | 539,805 | 2015-09-10 | Filing | |
| $22.55 | 1,620 | $36,529.38 | 998,336 | 2015-09-09 | Filing | |
| $22.55 | 380 | $8,568.62 | 540,805 | 2015-09-09 | Filing | |
| $22.61 | 1,000 | $22,614.80 | 999,956 | 2015-09-08 | Filing |
Institutional Investors' Holdings
News See All
Do Hedge Funds Love Dyax Corp. (DYAX)?
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in the third quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors...
Three Takeover Deals That Have Investors Excited Today
With the Fed having postponed the rate hike again, companies are taking full advantage of the low interest rates to finance their diversification and expansion plans.
Peter Kolchinsky's New Top Healthcare Pick And Old Favorites
Peter Kolchinsky's RA Capital Management recently filed its 13F with the SEC for the reporting period of June 30. Peter Kolchinsky started RA Capital Management after completing his Ph.D.
RA Capital's Latest Move In Alcobra Ltd (ADHD) Coming Off Hefty Second Quarter Gains
According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky's RA Capital has initiated a position in Alcobra Ltd (NASDAQ:ADHD), acquiring some 1.66 million shares of the...
Dyax Corp. (DYAX): Are Hedge Funds Right About This Stock?
Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.
Spectrum Pharmaceuticals, Inc. (SPPI): Are Hedge Funds Right About This Stock?
Now, according to many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age.
QLT Inc. (USA) (QLTI): Are Hedge Funds Right About This Stock?
In the financial world, there are many indicators shareholders can use to analyze Mr. Market. A pair of the most innovative are hedge fund and insider trading activity.
Dyax Corp. (DYAX), Shire PLC (ADR) (SHPG): An Interesting Bio Play in the Blood Disorder Niche
Thousands of Americans suffer from a rare and painful disease every year. This inherited disease is called Hereditary Angioedema, or HAE for short.
Billionaire Hedge Funds
